Skip to content
Vilantus Healthcare Pvt. Ltd.
livipro, image 1
GynaecologyCapsuleSchedule H Drug

livipro

Bifidobacterium breve 1.0 bilion cfu

Therapeutic Category:Details to be added

Active Formulation & CompositionStandard

Bifidobacterium breve 1.0 bilion cfu

Clinical Indications

Indications and clinical usage details to be added.

Packaging Specification

10*1*10

Pharmacological Features
  • Formulation details: Details to be added.
  • Bioavailability: Details to be added.
  • Stability: Details to be added.
Contact our team
Distribution & Franchise Information

Available for PCD Pharma Franchise & Third-Party Manufacturing. For distribution terms, territory availability, and inquiries, please connect with our representative.

Quality AssuredStandardised Process
Tested FormulationTechnical Testing
Batch DocumentationRecords Available
Timely DispatchLogistics Support